09.15.23 -- Are KRAS Inhibitors Poised To Cure Cancer?

The formulations for novel therapeutics require flexibility to support adaptive sterile manufacturing and an integrated approach for a path from development to small batch manufacturing, to commercialization.

Gain insight into how the quality control team at Almac Sciences developed processes and strategies to help ensure the high quality of safe and effective products while also maximizing efficiency.

Learn how industrial manufacturers are leveraging digital twins to accelerate the commissioning of new equipment and processes, as well as how best to get started with a virtual commissioning program.

Here, we share reasons a more scientific approach should be taken to differentiate between the 9,000 chemicals under the blanket categorization of per- and polyfluoroalkyl substances (PFAS).

The COVID-19 crisis acted as a catalyst for digital transformation in the healthcare industry. Learn how this transformation has impacted trends and new possibilities in the life sciences sector.

Discover how USP 1207, the reference standard for container closure integrity testing (CCIT), applies to the CCIT inspection method of intravenous (IV) bags.

Learn in detail how a CDMO helps biopharma organizations predict and mediate technical transfer risks before they become costly, time-consuming problems.

Finding the right manufacturing partner can be a complex endeavor, particularly for companies pursuing therapeutics with complex chemistries or spray-drying needs.

No single CDMO strategy or outsourcing model is appropriate for every project. Outsourcers can and should evaluate a strategy and partner(s) on a case-by-case basis.

bluebird bio's Scott Cleve sat down with the Business of Biotech podcast to talk about shifting regulatory standards and how pharmas can adapt how they engage with regulators.

A biopharmaceutical company known for its successful anti-infective products for adults sought to reformulate the product into an age-appropriate dosage form for young children and preteen patients.

Explore an integrated drug substance and drug product CMC strategy, along with technical case studies from process and analytical development that provide insight into tailored product specific solutions.

Gain insight into the proper timeline for process validation, the importance of linking the user requirements specification (URS) to each step of validation to ensure complete compliance, and more.

Understand the challenges and limitations of the blue dye test and compare the sensitivity of the blue dye test to other methods based on a comprehensive study.